– Company awarded 180 days marketing exclusivity – PITTSBURGH, Nov. 18, 2013 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Dexmethylphenidate Hydrochloride Extended-release (ER) Capsules, 30 mg, which is the first generic version of Novartis’ Focalin XR®. Mylan was the first company to have filed a substantially […]
Data Demonstrate Long-Term Expression of Functional Nerve Growth Factor in the Brain and Stabilization of Brain Cell Metabolic Activity RICHMOND, Calif., Nov. 15, 2013 /PRNewswire/ — Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today the presentation of positive data from the Phase 1 clinical trial of CERE-110 (AAV-NGF), a gene therapy approach designed to deliver nerve growth factor (NGF) for […]
LAVAL, Quebec, Nov. 15, 2013 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, has received notice that the New Drug Application for Luzu® (luliconazole) Cream, 1% has been approved by the United States Food and Drug Administration (FDA). Luzu® Cream, […]
Chef Art Smith makes a fire roasted corn salad
Chef Art Smith helps with healthy grocery shopping. SOURCE: Merck
Varian showcasing these and other X-ray imaging components at the 2013 Transport Security (TranSec) Expo in London this week LONDON, Nov. 14, 2013 /PRNewswire/ — A new flat-panel digital X-ray image detector designed especially for use in high-energy industrial and security imaging systems is among the imaging components that Varian Medical Systems (NYSE:VAR) is exhibiting at the 2013 […]
85% of subjects immunologically protected after receiving second dose of investigational cell culture vaccine when combined with proven MF59® adjuvant Vaccine now in large scale production highlighting rapid response capability of novel FDA licensed cell culture technology 135 confirmed cases and 45 deaths from H7N9 virus since emergence in March according to the World Health […]
Approach Selectively Represses Only the Disease-Causing Gene Resulting in Statistically Significant Effects on Symptoms and Other Biomarkers of Disease in Animal Models RICHMOND, Calif., Nov. 12, 2013 /PRNewswire/ — Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that positive preclinical data from their joint program with Shire plc to develop a novel ZFP Therapeutic® approach to Huntington’s disease (HD) were presented […]
E3 Grant Program helps health care institutions improve effectiveness, efficiency and excellence DUBLIN, Ohio, Nov. 11, 2013 /PRNewswire/ — The Cardinal Health Foundation is currently accepting applications for grant funding to help U.S., Canadian and Puerto Rican hospitals, health systems, community health clinics and other non-profit health care institutions improve the efficiency and quality of […]
GREENSBORO, N.C. – BUSINESS WIRE – Merz Pharma Group (Frankfurt am Main) announced that it has entered into a definitive agreement to acquire Anteis S.A., a Swiss company which specializes in the development, manufacture and commercialization of medical devices in the area of aesthetics. With products available in more than 90 countries on five continents, Anteis has been recognized as […]